2,667
Views
0
CrossRef citations to date
0
Altmetric
Dermatology

Association between vitiligo and sexual dysfunction: current evidence

, , , , , , , , , & ORCID Icon show all
Pages 946-953 | Received 23 Oct 2022, Accepted 10 Feb 2023, Published online: 09 Mar 2023

References

  • Liu W, Liu X-Y, Qian Y-T, et al. Urinary metabolomic investigations in vitiligo patients. Sci Rep. 2020;10(1):17989.
  • Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res. 2003;16(3):208–214.
  • Spritz RA. The genetics of vitiligo. J Invest Dermatol. 2011;131(E1):E18–E20.
  • Laddha NC, Dwivedi M, Mansuri MS, et al. Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol. 2013;22(4):245–250.
  • Rodrigues M, Ezzedine K, Hamzavi I, et al. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77(1):1–13. 10.1016/j.jaad.2016.10.048
  • Ezzedine K, Eleftheriadou V, Whitton M, et al. Vitiligo. Lancet. 2015;386(9988):74–84.
  • Trmoss and cjstevenson Incidence of male genital vitiligo. Br J Vener Dis. 1981;57:145–146.
  • Sukan M, Maner F. The problems in sexual functions of vitiligo and chronic urticaria patients. Journal of Sex & Marital Therapy. 2007;33(1):55–64.
  • Porter JR, Beuf AH, Lerner AB, et al. The effect of vitiligo on sexual relationships. J Am Acad Dermatol. 1990;22(2 Pt 1):221–222.
  • Porter J, Beuf A, Nordlund JJ, et al. Personal responses of patients to vitiligo: the importance of the patient-physician interaction. Arch Dermatol. 1978;114(9):1384–1385.
  • Papadopoulos L, Bor R, Legg C, et al. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol. 1998;23(6):243–248.
  • Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.
  • Ezzedine K, Eleftheriadou V, Jones H, et al. Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol. 2021;22(6):757–774.
  • Stang A. Critical evaluation of the newcastle–ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Khaled H, et al. Female sexual dysfunction in patients with psoriasis and vitiligo: an egyptian pilot study. J Egypt Women Dermatol Soc. 2021;18(1):22–34.
  • Sarhan D, Mohammed GFA, Gomaa AHA, et al. Female genital dialogues: female genital Self-Image, sexual dysfunction, and quality of life in patients with vitiligo with and without genital affection. J Sex Marital Ther. 2016;42(3):267–276.
  • Yucel D, Sener S, Turkmen D, et al. Evaluation of the dermatological life quality index, sexual dysfunction and other psychiatric diseases in patients diagnosed with vitiligo with and without genital involvement. Clin Exp Dermatol. 2021;46(4):669–674.
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283(15):2008–2012.
  • Mcgahuey AC, Gelenberg AJ, Laukes CA, et al. The Arizona sexual experience scale (ASEX): reliability and validity. Journal of Sex & Marital Therapy. 2000;26:25–40.
  • Anis TH, Gheit SA, Saied HS, et al. Arabic translation of female sexual function index and validation in an egyptian population. J Sex Med. 2011;8(12):3370–3378.
  • Lu T, Gao T, Wang A, et al. Vitiligo prevalence study in shaanxi province, China. Int J Dermatol. 2007;46(1):47e–451.
  • Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, et al. Quality of life with vitiligo: comparison of male and female muslim patients in Iran. Gender Medicine. 2006;3(2):124–130.
  • Alhetheli GI. The impact of vitiligo on patients’ psychological status and sexual function: cross-sectional questionnaire-based study. TODJ. 2021;15(1):23–30.
  • Wang K-Y, Wang K-H, Zhang Z-P, et al. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429–435.
  • Mechri A, Amri M, Douarika AA, et al. J. Psychiatric mor- bidity and quality of life in vitiligo: a case controlled study [in french]. Tunis Med. 2006;84(10):632–635.
  • Ongenae K, Dierckxsens L, Brochez L, et al. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005;210(4):279–285.
  • Ongenae K, Van Geel N, De Schepper S, et al. Effect of vitiligo on self- reported health-related quality of life. Br J Dermatol. 2005;152(6):1165–1172.
  • Prćić S, Durović D, Duran V, et al. Some psychological characteristics of children and adolescents with vitiligo: our results [in serbian]. Med Pregl. 2006;59(5-6):265–269.
  • Tsadik AG, Teklemedhin MZ, Mehari Atey T, et al. Public knowledge and attitudes towards vitiligo: a sur- vey in mekelle city, Northern Ethiopia. Dermatol Res Pract. 2020;2020:1–7.
  • Fatani MI, Aldhahri RM, Otaibi A, et al. Acknowledging popular misconceptions about vitiligo in Western Saudi Arabia. J Dermatol Dermatol Surg. 2016;20(1):27–31.
  • Juntongjin P, Rachawong C, Nuallaong W. Knowledge and attitudes towards vitiligo in the general population: a survey based on the simulation video of a real situation. Dermatol Sin. 2018;36(2):75–78.